Literature DB >> 2304968

A single-tube mathematical model of reactive hyperaemia.

S W Smye1, M I Bloor.   

Abstract

A mathematical model of reactive hyperaemia is developed using quasi-steady flow in a single tube to represent blood flow in the vascular bed. The role of the myogenic response during reactive hyperaemia is examined by suggesting a linear relationship between tube cross-sectional area S and pressure p, in which S decreases as p increases, thereby modelling the response of the smooth muscle in the blood vessel walls to increases in p which the myogenic mechanism proposes. However, this simple relationship, together with the equations of continuity and Poiseuille flow, lead to an unstable equation for p which is inconsistent with the known boundary conditions. It is necessary to make S a function of p and delta p/delta t in order to achieve a stable response which implies that the myogenic response must be rate sensitive to pressure changes. The resulting equations are then solved for p, S, and flow Q by numerical integration and give results for Q which are in broad agreement with experiment. The model also suggests that the changing pressure gradient governs the flow in reactive hyperaemia rather than changes in the resistance of the blood vessels.

Mesh:

Year:  1990        PMID: 2304968     DOI: 10.1088/0031-9155/35/1/010

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  3 in total

1.  Prediction of reactive hyperaemia in vascular pathologies using elastic porous tube model.

Authors:  S W Smye; M I Bloor
Journal:  Med Biol Eng Comput       Date:  1995-03       Impact factor: 2.602

2.  Elastic porous tube model of reactive hyperaemia.

Authors:  S W Smye; M I Bloor
Journal:  Med Biol Eng Comput       Date:  1994-09       Impact factor: 2.602

3.  Simplified model of laser Doppler signals during reactive hyperaemia.

Authors:  A Humeau; J L Saumet; J P L'Huillier
Journal:  Med Biol Eng Comput       Date:  2000-01       Impact factor: 3.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.